Quantumzyme Corp., a biotransformation company developing enzyme-based solutions for pharmaceutical manufacturing, announced it will attend the 2026 BIO International Convention scheduled for June 22–25, 2026, in San Diego, California. The company's participation will be limited to observation and informal networking meetings, with no formal presentations, exhibitions, or sponsorship planned.
The BIO International Convention represents a significant global gathering for biotechnology and life sciences companies, academic institutions, and industry participants across various scientific and commercial disciplines. Quantumzyme's attendance at this event underscores the company's strategic focus on increasing industry awareness and maintaining dialogue with potential collaborators, technology partners, and other stakeholders in the biotechnology ecosystem.
"We view the BIO International Convention as an important opportunity to connect with peers across the biotechnology and biomanufacturing ecosystem," said Naveen Kulkarni, Chief Executive Officer of Quantumzyme Corp. "Our attendance is focused on listening, learning, and engaging in informal discussions with industry participants as we continue to evaluate developments relevant to our technology and long-term objectives."
Quantumzyme specializes in applying quantum mechanics, molecular modeling, AI-driven simulations, and computational enzyme engineering to develop biocatalysts designed to enhance efficiency, reduce waste, and support environmentally responsible pharmaceutical production. The company's approach integrates computational modeling with laboratory validation to create scalable, cost-effective biocatalysis solutions that aim to improve industrial sustainability through green chemistry principles.
The company noted that there can be no assurance that discussions initiated during the conference will result in any agreements, transactions, or future business relationships. Additional information regarding the BIO International Convention is available at https://convention.bio.org.
For more information about Quantumzyme, investors and interested parties can visit the company's website at https://www.quantumzymecorp.com and the company's profile at https://www.otcmarkets.com/stock/QTZM.
